PE/Cyanine7 anti-mouse CD107a (LAMP-1) Antibody
- 产品名称：
- PE/Cyanine7 anti-mouse CD107a (LAMP-1) Antibody
- 产品类别：
- 抗体
- 产品编号：
- 121619
- 产品应用：
- 121619
- Verified Reactivity
- Mouse
- Antibody Type
- Monoclonal
- Host Species
- Rat
- Immunogen
- This monoclonal antibody was raised against NIH/3T3 mouse embryonic fibroblast tissue culture cell membranes. It has been mapped to the N-terminus of LAMP-1.
- Formulation
- Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
- Preparation
- The antibody was purified by affinity chromatography and conjugated with PE/Cyanine7 under optimal conditions.
- Concentration
- 0.2 mg/ml
- Storage & Handling
- The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
- Application
-
FC - Quality tested
- Recommended Usage
Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤1.0 ?g per million cells in 100 ?l volume. It is recommended that the reagent be titrated for optimal performance for each application.
- Excitation Laser
- Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)
- Additional Product Notes
BioLegend is in the process of converting the name PE/Cy7 to PE/Cyanine7. The dye molecule remains the same, so you should expect the same quality and performance from our PE/Cyanine7 products. Please contact Technical Service if you have any questions.
- Product Citations
-
- Lee Y, et al. 2020. J Innate Immun. 1:. PubMed
- Xu ZH, et al. 2021. Mediators Inflamm. 2021:8856326. PubMed
- Rafiq S, et al. 2018. Nat Biotechnol. 36:847. PubMed
- Cuff AO, et al. 2020. Frontiers in Immunology. 1.930555556. PubMed
- Tran L, et al. 2017. Cancer Immunol Res. 5:1141. PubMed
- Markov SD, et al. 2021. Mol Cancer Ther. 20:2457. PubMed
- Lam JH, et al. 2017. JCI Insight. 2:e94500. PubMed
- Maluski M, et al. 2019. J Clin Invest. 129:5108. PubMed
- Pais Ferreira D, et al. 2020. Immunity. 53(5):985-1000.e11. PubMed
- Jakic B, et al. 2021. Cell Death Dis. 12:187. PubMed
- Liang J, et al. 2020. Sci Adv. 6:eabc3646. PubMed
- XS R, et al. 2015. Diabetes. 64 90. PubMed
- Simula L et al. 2018. Cell reports. 25(11):3059-3073 . PubMed
- Leclerc M, et al. 2019. Nat Commun. 10:3345. PubMed
- RRID
- AB_2562146 (BioLegend Cat. No. 121619) AB_2562147 (BioLegend Cat. No. 121620)
